Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Brighton Pier profit surges on strong summer

Mon, 28th Mar 2022 10:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cambridge Cognition Holdings PLC, up 13% at 136.94 pence, 12-month range 82.00p-195.00p. The Cambridge-based neuroscience technology company wins a "pivotal" GBP1 million pact concerning an autoimmune trial. Cambridge Cognition has been picked by a "top 10 pharmaceutical company" to provide digital cognitive assessments for the phase III probe. "Revenue from the contract is expected over the next three years," the AIM listing says.

----------

Brighton Pier Group PLC, up 9.8% at 92.22 pence, 12-month range 34.00p-97.20p. The company, which operates Brighton Marine Palace as well as bars and indoor mini-golf sites, says annual earnings jump. Revenue in the financial year that ended December 26 rise sharply to GBP22.8 million from GBP8.2 million. Pretax profit multiplies to GBP6.6 million from GBP2.7 million. Brighton Pier attributes its stronger top and bottom line figures a "record summer trading period". Shares hit this one-year high on Monday.

----------

AIM - LOSERS

----------

Summerway Capital PLC down 8.9% at 144.00p, 12-month range 90.00p-278.50p. Shares fall following completion of acquisition of Vertigrow Technology Ltd, or Celadon Pharmaceuticals. Name change to Celadon Pharmaceuticals PLC will take effect on Tuesday. Celadon is acquired by way of reverse takeover worth GBP80 million. Summerway funds the deal through an issue of 48.5 million shares at 165 pence each. Summerway, which prior to acquisition invested in household and consumer goods sectors, is now a cannabinoid-based-medicine-focused pharmaceutical company.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2019 10:37

Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push

Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push

Read more
26 Sep 2019 16:33

DIRECTOR DEALINGS: Cambridge Cognition Boss Matthew Stork Buys Shares

DIRECTOR DEALINGS: Cambridge Cognition Boss Matthew Stork Buys Shares

Read more
23 Sep 2019 17:13

DIRECTOR DEALINGS: Cambridge Cognition Non-Executive Chair Buys Shares

DIRECTOR DEALINGS: Cambridge Cognition Non-Executive Chair Buys Shares

Read more
19 Sep 2019 11:52

Cambridge Cognition Interim Revenue Falls As Clinical Trial Sales Lag

(Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC on Thursday reported a fall in interim revenue in line with previous guidance that sales were lower than the six

Read more
12 Sep 2019 16:21

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 13 September  JD WetherspoonFull Year ResultsSthreeQ3 Enterprise Investment

Read more
27 Aug 2019 10:28

WINNERS & LOSERS SUMMARY: Carpetright Up After Shareholder Helps Out

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - LOSERS----------Ferguson,

Read more
27 Aug 2019 09:35

Cambridge Cognition Shares Plunge 40% On Increased Loss Guidance

(Alliance News) - Shares in Cambridge Cognition Holdings PLC collapsed Tuesday after the company said it expects to report its loss widened in the first half due to "difficult" trading a

Read more
27 Aug 2019 09:17

Cambridge Cognition shares tumble after profit warning

(Sharecast News) - Digital solutions developer Cambridge Cognition warned on Tuesday that interim losses looked set to widen after revenues dwindled and costs grew in the six months ended 30 June.

Read more
19 Jul 2019 10:37

Cambridge Cognition Inks NeuroVocalix Deal With Pharma Firm

(Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC said it has secured a second commercial partnership with an undisclosed pharmaceutical company for its in the at

Read more
1 Jul 2019 15:48

Cambridge Cognition Names Vertual Boss Debra Leeves As Non-Executive

(Alliance News) - Cambridge Cognition Holdings PLC on Monday said it appointed Debra Leeves as a non-executive director with immediate effect.The neuroscience technology company said Leeves

Read more
25 Apr 2019 14:13

Cambridge Cognition To Shuffle Leadership Team At AGM

LONDON (Alliance News) - Neuroscience firm Cambridge Cognition Holdings PLC on Thursday announced a change of leadership at its upcoming annual general meeting.Cambridge Cognition's be

Read more
19 Mar 2019 11:20

Cambridge Cognition wins biggest digital health contract to date

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced a "significant" new contract on Tuesday, providing its digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.

Read more
14 Mar 2019 14:03

Lombard Odier Asset Management Holds 5.8% Cambridge Cognition Stake (ALLISS)

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that Lombard Odier Asset Management Europe Ltd holds a 5.75% stake in the cognitive assessment software firm after a on the

Read more
7 Mar 2019 12:32

Cambridge Cognition slips as low order intake sends loss deeper

(Sharecast News) - Cambridge Cognition's shares slipped on Thursday after it reported that low order intake from 2017 had caused its annual losses to widen and revenues to fall.

Read more
31 Jan 2019 13:28

Cambridge Cognition soars on Indian software partnership

(Sharecast News) - Cambridge Cognition leapt on Thursday after entering a partnership with a major pharmaceutical company to deliver online neurological testing to patients in India using its cloud-based CANTAB Connect platform.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.